blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3980786

EP3980786 - METHODS OF IDENTIFYING ATTRIBUTES OF THERAPEUTIC PROTEINS [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  13.09.2024
Database last updated on 22.01.2025
FormerGrant of patent is intended
Status updated on  15.05.2024
FormerExamination is in progress
Status updated on  19.01.2023
FormerRequest for examination was made
Status updated on  11.03.2022
FormerThe international publication has been made
Status updated on  11.12.2020
Formerunknown
Status updated on  13.08.2020
Most recent event   Tooltip18.10.2024Change - divisional application(s)published on 20.11.2024  [2024/47]
Applicant(s)For all designated states
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320-1799 / US
[2024/24]
Former [2022/15]For all designated states
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, California 91320 / US
Inventor(s)01 / BONDARENKO, Pavel
c/o Amgen Inc., One Amgen Center Drive
Law Department-Patent Operations
Mail Stop 28-5-A
Thousand Oaks, California 91320-1799 / US
02 / CROUSE-ZEINEDDINI, Jill A.
c/o Amgen Inc., One Amgen Center Drive
Law Department-Patent Operations
Mail Stop 28-5-A
Thousand Oaks, California 91320-1799 / US
03 / KUHNS, Scott Thomas
c/o Amgen Inc., One Amgen Center Drive
Law Department-Patent Operations
Mail Stop 28-5-A
Thousand Oaks, California 91320-1799 / US
04 / NICHOLS, Andrew
c/o Amgen Inc., One Amgen Center Drive
Law Department-Patent Operations
Mail Stop 28-5-A
Thousand Oaks, California 91320-1799 / US
05 / XIAO, Gang
c/o Amgen Inc., One Amgen Center Drive
Law Department-Patent Operations
Mail Stop 28-5-A
Thousand Oaks, California 91320-1799 / US
06 / SHI, Rachel Liuqing
c/o Amgen Inc., One Amgen Center Drive
Law Department-Patent Operations
Mail Stop 28-5-A
Thousand Oaks, California 91320-1799 / US
 [2024/42]
Former [2022/15]01 / BONDARENKO, Pavel
c/o Amgen Inc., One Amgen Center Drive Law
Department-Patent Operations, Mail Stop 28-5-A
Thousand Oaks, California 91320-1799 / US
02 / CROUSE-ZEINEDDINI, Jill A.
c/o Amgen Inc., One Amgen Center Drive Law
Department-Patent Operations, Mail Stop 28-5-A
Thousand Oaks, California 91320-1799 / US
03 / KUHNS, Scott Thomas
c/o Amgen Inc., One Amgen Center Drive Law
Department-Patent Operations, Mail Stop 28-5-A
Thousand Oaks, California 91320-1799 / US
04 / NICHOLS, Andrew
c/o Amgen Inc., One Amgen Center Drive Law
Department-Patent Operations, Mail Stop 28-5-A
Thousand Oaks, California 91320-1799 / US
05 / XIAO, Gang
c/o Amgen Inc., One Amgen Center Drive Law
Department-Patent Operations, Mail Stop 28-5-A
Thousand Oaks, California 91320-1799 / US
06 / SHI, Rachel Liuqing
c/o Amgen Inc., One Amgen Center Drive Law
Department-Patent Operations, Mail Stop 28-5-A
Thousand Oaks, California 91320-1799 / US
Representative(s)Dörries, Hans Ulrich
df-mp Dörries Frank-Molnia & Pohlman
Patentanwälte Rechtsanwälte PartG mbB
Theatinerstrasse 16
80333 München / DE
[2022/15]
Application number, filing date20750792.205.06.2020
[2022/15]
WO2020US36380
Priority number, dateUS201962857637P05.06.2019         Original published format: US 201962857637 P
US202062968682P31.01.2020         Original published format: US 202062968682 P
[2022/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020247790
Date:10.12.2020
Language:EN
[2020/50]
Type: A1 Application with search report 
No.:EP3980786
Date:13.04.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 10.12.2020 takes the place of the publication of the European patent application.
[2022/15]
Type: B1 Patent specification 
No.:EP3980786
Date:16.10.2024
Language:EN
[2024/42]
Search report(s)International search report - published on:EP10.12.2020
ClassificationIPC:G01N33/68
[2022/15]
CPC:
G01N33/6848 (EP,US); G01N33/6845 (EP,US); G01N33/54306 (US);
G01N33/547 (US); G01N2500/20 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/15]
Extension statesBA29.12.2021
ME29.12.2021
Validation statesKH29.12.2021
MA29.12.2021
MD29.12.2021
TN29.12.2021
TitleGerman:METHODEN ZUR IDENTIFIZIERUNG VON ATTRIBUTEN THERAPEUTISCHER PROTEINE[2024/22]
English:METHODS OF IDENTIFYING ATTRIBUTES OF THERAPEUTIC PROTEINS[2022/15]
French:PROCÉDÉS D'IDENTIFICATION D'ATTRIBUTS DE PROTÉINES THÉRAPEUTIQUES[2022/15]
Former [2022/15]VERFAHREN ZUR IDENTIFIZIERUNG VON EIGENSCHAFTEN THERAPEUTISCHER PROTEINE
Entry into regional phase29.12.2021National basic fee paid 
29.12.2021Designation fee(s) paid 
29.12.2021Examination fee paid 
Examination procedure29.12.2021Examination requested  [2022/15]
29.12.2021Date on which the examining division has become responsible
05.07.2022Amendment by applicant (claims and/or description)
18.01.2023Despatch of a communication from the examining division (Time limit: M04)
22.05.2023Reply to a communication from the examining division
21.09.2023Despatch of a communication from the examining division (Time limit: M04)
12.01.2024Reply to a communication from the examining division
16.05.2024Communication of intention to grant the patent
10.09.2024Fee for grant paid
10.09.2024Fee for publishing/printing paid
10.09.2024Receipt of the translation of the claim(s)
Divisional application(s)EP24206415.2
Fees paidRenewal fee
21.06.2022Renewal fee patent year 03
20.06.2023Renewal fee patent year 04
19.06.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inby applicantUS7153507
 US7592429
 US7982016
 US8080243
 US8101182
 US8715663
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.